JB
Bögeholz J
University Hospital Zurich, Stanford University
Research areas: Medicine · Pathology and Forensic Medicine · Lymphoma Diagnosis and Treatment · Cancer Genomics and Diagnostics · Chronic Lymphocytic Leukemia Research
0000-0002-7196-1621
Employment
- 2023 - Present
-
Stanford University Postdoc2019 - 2023
-
University Hospital of Zurich Resident fellow2017 - 2019
-
University Hospital of Zurich Resident fellow2015 - 2017
Education
Education history is unavailable.
Projects & Funding
-
Postdoc Bursary program Swiss Cancer Leagur2019 - 2021
Publications (23)
- Clonal hematopoiesis and cytopenias following CAR19 therapy Save
- Abstract 6560: Cell-free RNA analysis for non-invasive cancer detection and characterization Save
- Detection of Scedosporium spp.: Colonizer or pathogen? A retrospective analysis of clinical significance and management in a large tertiary center. Save
- Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Save
- An Integrated Multimodal Framework for Noninvasive TCL Disease Detection and Monitoring Save
- CAR19 Therapy Drives Expansion of Clonal Hematopoiesis and Associated Cytopenias Save
- Distinct Circulating Genomic Features of Classical Hodgkin Lymphoma of Older Adults Save
- Genomic, Transcriptional, and Immunological Validation of Distinct Molecular Subtypes of Classic Hodgkin Lymphoma through Tissue-Based and Noninvasive Methods Save
- Inferred Gene Expression By Cell-Free DNA Profiling Allows Noninvasive Lymphoma Classification Save
- 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023. Save
- 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023. Save
- Abstract 1045: RePhyNER: Overcoming limitations of access to matched germline for serial liquid biopsy applications Save
- Clonal Hematopoiesis Driven By Recurrent Somatic Mutations but Not with Recurrent Copy Number Alterations Is Associated with Inferior Outcomes in DLBCL after Induction Chemotherapy, but Not CAR19 Therapy Save
- Tumor Microenvironment Determinants of Immunotherapy Response Identified By Integrated Host & Viral Analysis of Post-Transplant Lymphoproliferative Disorders Save
- Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report Save
- CLONAL HEMATOPOIESIS IS ASSOCIATED WITH INFERIOR PROGNOSIS IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS Save
- Clinical Relevance of Anti-TNF Antibody Trough Levels and Anti-Drug Antibodies in Treating Inflammatory Bowel Disease Patients. Save
- Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect. Save
- Intrakranielle Hypertension – und was macht der Blutdruck? Save
- Long-Term Follow-Up of Antibody Titers Against Measles, Mumps, and Rubella in Recipients of Allogenic Hematopoietic Cell Transplantation. Save